We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

72 hedge funds and large institutions have $23.3M invested in Surgalign Holdings, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more call options, than puts

Call options by funds: $180K | Put options by funds: $127K

10% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 20

19% less funds holding

Funds holding: 8972 (-17)

53% less capital invested

Capital invested by funds: $49.1M → $23.3M (-$25.8M)

61% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 28

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
72
Holders Change
-17
Holders Change %
-19.1%
% of All Funds
1.11%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
11
Increased
18
Reduced
20
Closed
28
Calls
$180K
Puts
$127K
Net Calls
+$53K
Net Calls Change
+$203K
Name Holding Trade Value Shares
Change
Change in
Stake
First Eagle Investment Management
26
First Eagle Investment Management
New York
$68K +$17.8K +666 +26%
GTAM
27
Global Trust Asset Management
Florida
$65K +$81.1K +3,033 New
Goldman Sachs
28
Goldman Sachs
New York
$58K -$245K -9,167 -77%
DI
29
DFPG Investments
Utah
$47K -$325K -12,167 -85%
YCM
30
Yakira Capital Management
Connecticut
$46K
Rafferty Asset Management
31
Rafferty Asset Management
New York
$43K +$53.5K +2,002 New
GCP
32
GSA Capital Partners
United Kingdom
$42K +$26.1K +975 +101%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$34K -$214K -8,003 -83%
Osaic Holdings
34
Osaic Holdings
Arizona
$32K +$5.03K +188 +15%
Jane Street
35
Jane Street
New York
$31K -$116K -4,327 -75%
Charles Schwab
36
Charles Schwab
California
$30K
Optiver Holding
37
Optiver Holding
Netherlands
$30K
Russell Investments Group
38
Russell Investments Group
United Kingdom
$30K
Envestnet Asset Management
39
Envestnet Asset Management
Illinois
$27K +$5.03K +188 +18%
GF
40
Gabelli Funds
New York
$25K -$258K -9,658 -89%
CAN
41
Cetera Advisor Networks
California
$21K +$26.2K +980 New
CTC
42
Central Trust Company
Missouri
$21K +$26.5K +992 New
EGM
43
Engineers Gate Manager
New York
$17K +$8.93K +334 +75%
CA
44
Calton & Associates
Florida
$16K -$160 -6 -0.8%
AWA
45
Acorn Wealth Advisors
Michigan
$16K +$19.8K +742 New
Stifel Financial
46
Stifel Financial
Missouri
$14K
TCM
47
Traynor Capital Management
Pennsylvania
$14K
TA
48
Teton Advisors
New York
$13K -$13.4K -500 -45%
Victory Capital Management
49
Victory Capital Management
Texas
$12K -$508 -19 -3%
MML Investors Services
50
MML Investors Services
Massachusetts
$12K

SRGA Hedge Fund Activity: Q4 2021 in Review

72 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2021, worth a combined $23.3M — down 53% from $49.1M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of SRGA and 11 opened new positions — a net loss of 17 holders — while 20 trimmed existing stakes and 18 added.

The largest buyer was Cooperman Leon G, adding an estimated $1.59M. The largest seller was Krensavage Asset Management, exiting entirely with an estimated $6.9M sold.

  • 72 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2021, down from 89 in Q3 2021.
  • Funds reported $23.3M of Surgalign Holdings, Inc. Common Stock stock for Q4 2021, down 53% quarter-over-quarter.
  • 11 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2021 and 28 closed out, a net change of -17 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2021 was Cooperman Leon G, an estimated $1.59M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2021 was Krensavage Asset Management, an estimated $6.9M sold.

Based on aggregated 13F filings for Q4 2021.